Blog | Gen Re

Our Perspective

A Blood Test Can’t Detect Cancer, Can It?

By Andres Webersinke |February 06, 2018|English | Deutsch

We began 2018 with some promising news on cancer: A simple blood test can now detect disease in eight common sites. Called the CancerSEEK test, it was developed at the Johns Hopkins Kimmel Cancer Center, and may herald a new age in cancer medicine. How...
Read More
Stroke in Younger Adults - Have Improvements Reached Their Limit?

By Dr. Chris Ball |December 18, 2017|English

Age remains the most consistent risk factor for ischaemic stroke. Surprisingly then an estimated 10% of diagnoses are now seen in people below the age of 50. In many countries vigorous management of vascular risk coupled to improved stroke services...
Read More
Lump Sum Benefits - The Experience in New Zealand

By Li Wen Beh and Winncy Wong |November 28, 2017|English

Read More
Progress in the Management of Multiple Sclerosis

By Dr. Chris Ball |November 23, 2017|English

Multiple Sclerosis (MS) presents a challenge to insurers due to its complex, unpredictable course. MS is a covered condition in “Critical Illness” insurance policies sold in markets across Asia, in the UK and Ireland, South Africa, New Zealand...
Read More
Genetic Testing and the Power of Knowledge

By Annika Tiedemann |November 16, 2017|English

Using genetic testing to make treatment decisions on serious medical conditions, such as cancer, is becoming more common. Approved tests number in the thousands, and the costs associated with genome sequencing have fallen sharply. Most genetic tests...
Read More
Opportunity Is Knocking - Will You Answer?

By Steve Rowley|November 13, 2017|English

Gen Re has just completed our 16th annual U.S. Critical Illness Market Survey. The data gathered from 53 participating carriers captures a moment-in-time snapshot of where the market is today. This snapshot comes to life when we look to the historical...
Read More